Diff Profiles › MTBLS2324_0001_00000001

G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448

RPMI_modified_Blood_M1T1_5448 vs Pooled_sera_Blood_M1T1_5448

p-value ≤ 0.05 39 significant 2025-09-26 00:00:00 Study: MTBLS2324
119 Total Features
39 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS2324_0001_00000001
Linked study
MTBLS2324 — Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pyogenes assays)
Comparison
RPMI_modified_Blood_M1T1_5448 vs Pooled_sera_Blood_M1T1_5448
Group A
Samples from Streptococcus pyogenes M1T1 clone 5448 grown in RPMI modified media from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.
Group B
Samples from Streptococcus pyogenes M1T1 clone 5448 grown in pooled sera from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.
Total features tested
119
Significant features
39
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
HVYWMOMLDIMFJA-DPAQBDIFSA-N CHOLESTEROL down 0.004865 0.000124
GXIURPTVHJPJLF-UHFFFAOYSA-N 3-hydroxy-2-(phosphonooxy)propanoic acid up 37.64 2.54e-05
DTBNBXWJWCWCIK-UHFFFAOYSA-N PEP up 46.19 6.47e-05
OSJPPGNTCRNQQC-UHFFFAOYSA-N Glycerate 3-phosphate up 29.74 2.26e-05
RWQNBRDOKXIBIV-UHFFFAOYSA-N 5-Methyluracil up 8.428 1.75e-07
VYFYYTLLBUKUHU-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)ethylamine up 11.41 0.00024
GHOKWGTUZJEAQD-UHFFFAOYSA-N <em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-β-alanine up 13.84 0.000889
RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid up 6.54 0.000117
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-2-Amino-3-hydroxybutyric acid up 19.3 0.00361
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-Ribose up 5.967 0.000386